Changeflow GovPing Healthcare & Life Sciences SPSIPB vs ESPB Block for Breast Surgery Pain
Routine Notice Added Final

SPSIPB vs ESPB Block for Breast Surgery Pain

Favicon for changeflow.com ClinicalTrials.gov Studies
Published
Detected
Email

Summary

NIH registered ClinicalTrials.gov Study NCT07541040, a prospective randomized assessor-blinded trial comparing serratus posterior superior intercostal plane block (SPSIPB) and erector spinae plane block (ESPB) for postoperative analgesia in unilateral breast surgery. 54 patients will be randomized to receive either intervention before general anesthesia. Primary outcome is postoperative pain scores within 24 hours; secondary outcome is opioid consumption.

Published by NIH on changeflow.com . Detected, standardized, and enriched by GovPing. Review our methodology and editorial standards .

What changed

NIH registered ClinicalTrials.gov Study NCT07541040, a prospective randomized controlled trial comparing two regional anesthesia techniques for breast surgery. The study will enroll 54 patients randomized to receive either serratus posterior superior intercostal plane block (SPSIPB) or erector spinae plane block (ESPB) prior to general anesthesia. No regulatory obligations or compliance requirements are imposed by this registration. Clinical investigators and anesthesiology departments conducting similar regional anesthesia research should note the comparative endpoints (pain scores and opioid consumption) as standard outcome measures for this procedure class.

Archived snapshot

Apr 22, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

← ClinicalTrials.gov Studies

Serratus vs ESP Block for Postoperative Pain in Unilateral Breast Surgery: A Randomized Study

N/A NCT07541040 Kind: NA Apr 21, 2026

Abstract

This prospective, randomized, assessor-blinded trial compares serratus posterior superior intercostal plane block (SPSIPB) and erector spinae plane block (ESPB) for postoperative analgesia in unilateral breast surgery. 54 patients will be randomized to receive either SPSIPB or ESPB before general anesthesia.

The primary outcome is postoperative pain scores within the first 24 hours. The secondary outcome is opioid consumption.

Conditions: Post Operative Pain, Opioid Use

Interventions: Serratus Posterior Superior Intercostal Plane Block

View original document →

Get daily alerts for ClinicalTrials.gov Studies

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from NIH.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
NIH
Published
April 21st, 2026
Instrument
Notice
Branch
Executive
Legal weight
Non-binding
Stage
Final
Change scope
Minor

Who this affects

Applies to
Healthcare providers Clinical investigators
Industry sector
3345 Medical Device Manufacturing
Activity scope
Clinical trial registration Postoperative pain management Regional anesthesia
Geographic scope
United States US

Taxonomy

Primary area
Healthcare
Operational domain
Clinical Operations
Topics
Medical Devices Pharmaceuticals

Get alerts for this source

We'll email you when ClinicalTrials.gov Studies publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!